Impact of Drug-Eluting Versus Bare-Metal Stents on Mortality in Patients With Anemia

JACC: Cardiovascular Interventions

Volumn 2, Issue 4, 2009, Pages 329-336

  Shishehbor, Mehdi H ^a   Filby, Steven J ^a   Chhatriwalla, Adnan K ^a   Christofferson, Ryan D ^a   Jain, Anil ^a   Kapadia, Samir R ^a   Lincoff, A Michael ^a   Bhatt, Deepak L ^a   Ellis, Stephen G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

all cause mortality; anemia; bare metal stents; drug eluting stents

Indexed keywords

ADULT; ANEMIA; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DEATH; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; HEMATOCRIT; HIGH RISK PATIENT; HUMAN; INCIDENCE; MACROCYTIC ANEMIA; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MEDICAL DECISION MAKING; MICROCYTIC ANEMIA; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT OUTCOME;

AGED; ANEMIA; ANEMIA, MACROCYTIC; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; ERYTHROCYTE INDICES; FEMALE; HEMATOCRIT; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METALS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 64749116446     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.11.014     Document Type: Article

References (34)

1. Carson J.L., Duff A., Poses R.M., et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 348 (1996) 1055-1060
2. Chonchol M., and Nielson C. Hemoglobin levels and coronary artery disease. Am Heart J 155 (2008) 494-498
3. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
4. Wu W.C., Rathore S.S., Wang Y., Radford M.J., and Krumholz H.M. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 (2001) 1230-1236
5. Zindrou D., Taylor K.M., and Bagger J.P. Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. Lancet 359 (2002) 1747-1748
6. Catakoglu A.B., Aytekin S., Sener M., et al. Impact of anemia on nonfatal coronary events after percutaneous coronary interventions. Heart Vessels 22 (2007) 383-388
7. Lee P.C., Kini A.S., Ahsan C., Fisher E., and Sharma S.K. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 44 (2004) 541-546
8. McKechnie R.S., Smith D., Montoye C., et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 110 (2004) 271-277
9. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50 (2007) e1-e157
10. Diez Roux A.V., Merkin S.S., Arnett D., et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med 345 (2001) 99-106
11. Shishehbor M.H., Litaker D., Pothier C.E., and Lauer M.S. Association of socioeconomic status with functional capacity, heart rate recovery, and all-cause mortality. JAMA 295 (2006) 784-792
12. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 405 (1968) 5-37
13. Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep 47 (1998) 1-29
14. Nikolsky E., Mehran R., Aymong E.D., et al. Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 94 (2004) 1023-1027
15. Win H.K., Caldera A.E., Maresh K., et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 297 (2007) 2001-2009
16. Spertus J.A., Kettelkamp R., Vance C., et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113 (2006) 2803-2809
17. Ong A.T., McFadden E.P., Regar E., de Jaegere P.P., van Domburg R.T., and Serruys P.W. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 (2005) 2088-2092
18. McFadden E.P., Stabile E., Regar E., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
19. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
20. Camenzind E., Steg P.G., and Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 115 (2007) 1440-1455 discussion 1455
21. Lagerqvist B., James S.K., Stenestrand U., Lindback J., Nilsson T., and Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
22. Nordmann A.J., Briel M., and Bucher H.C. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 27 (2006) 2784-2814
23. Tu J.V., Bowen J., Chiu M., et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 357 (2007) 1393-1402
24. Marzocchi A., Saia F., Piovaccari G., et al. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation 115 (2007) 3181-3188
25. Applegate R.J., Sacrinty M.T., Kutcher M.A., et al. "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol 51 (2008) 607-614
26. Rao S.V., Shaw R.E., Brindis R.G., Klein L.W., Weintraub W.S., and Peterson E.D. On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]). Am J Cardiol 97 (2006) 1478-1481
27. Beohar N., Davidson C.J., Kip K.E., et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 297 (2007) 1992-2000
28. Serruys P.W., de Jaegere P., Kiemeneij F., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331 (1994) 489-495
29. Fischman D.L., Leon M.B., Baim D.S., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331 (1994) 496-501
30. Walters D.L., Harding S.A., Walsh C.R., Wong P., Pomerantsev E., and Jang I.K. Acute coronary syndrome is a common clinical presentation of in-stent restenosis. Am J Cardiol 89 (2002) 491-494
31. Chen M.S., John J.M., Chew D.P., Lee D.S., Ellis S.G., and Bhatt D.L. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 151 (2006) 1260-1264
32. Nayak A.K., Kawamura A., Nesto R.W., et al. Myocardial infarction as a presentation of clinical in-stent restenosis. Circ J 70 (2006) 1026-1029
33. Bossi I., Klersy C., Black A.J., et al. In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. J Am Coll Cardiol 35 (2000) 1569-1576
34. Budaj A., Yusuf S., Mehta S.R., et al. Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation 106 (2002) 1622-1626